Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
Medtronic
Moodys
UBS
Mallinckrodt

Generated: September 19, 2019

DrugPatentWatch Database Preview

Patent: 7,534,784

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,534,784
Title:CGRP receptor antagonists
Abstract: The present invention is directed to compounds of Formula I: ##STR00001## (where variables R.sup.1, R.sup.2, R.sup.3, R.sup.4, A, B, G, J, Q, T, U, V, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
Inventor(s): Burgey; Christopher S. (Philadelphia, PA), Deng; Zhengwu J. (Eagleville, PA), Nguyen; Diem N. (Harleysville, PA), Paone; Daniel V. (Blue Bell, PA), Shaw; Anthony W. (Harleysville, PA), Williams; Theresa M. (Harleysville, PA)
Assignee: Merck + Co., Inc. (Rahway, NJ)
Application Number:12/082,233
Patent Claims:see list of patent claims

Details for Patent 7,534,784

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02 ➤ Sign Up Merck + Co., Inc. (Rahway, NJ) 2023-04-15 RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Sign Up Merck + Co., Inc. (Rahway, NJ) 2023-04-15 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
McKesson
Farmers Insurance
Teva
AstraZeneca
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.